Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2000
09/21/2000WO2000026242A3 Dna replication-regulating genes, antibodies thereto and diagnostic applications thereof
09/21/2000WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000024898A8 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect
09/21/2000WO2000022115A3 Assays for identifying functional alterations in the p53 tumor suppressor
09/21/2000WO2000022001A3 A potassium channel of the erg family
09/21/2000WO2000021989A9 Decorin binding proteins dbp a and b and genes encoding them
09/21/2000WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
09/21/2000WO2000020574A3 Fusions of scaffold proteins with random peptide libraries
09/21/2000WO2000020571A3 Maize promoters
09/21/2000WO2000020451A3 Anti-mitotic agents and processes
09/21/2000WO2000018800A9 Novel secreted immunomodulatory proteins and uses thereof
09/21/2000WO2000018783A9 Mammaglobin, a secreted mammary-specific breast cancer protein
09/21/2000WO2000017334A3 Analysis of ligand activated nuclear receptors i(in vivo)
09/21/2000WO2000016746A9 Immunogenic liposome compositions
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000010602A9 Lats knock-out animal models and their uses
09/21/2000WO2000009074B1 Variable output applicator and method for multi-component biologic fluid agents, and application method
09/21/2000WO2000007427A3 Method for selective and optionally reversible degeneration of somatic plant tissue
09/21/2000DE19910912A1 New human RET proto-oncogene variants for determining disease disposition and tailoring specific individual therapies, for e.g. multiple endocrine neoplasia syndrome type 2A or for familial medullary thyroid gland carcinoma
09/21/2000DE19910419A1 Zielzellspezifische, multivalente Proteine (MVP) Target cell-specific, multivalent proteins (MVP)
09/21/2000DE19853778C1 DNA-Sequenzen kodierend einen Glutamat/Malat-Translokator, Plasmide Bakterien, Hefen und Pflanzen enthaltend diesen Transporter DNA sequences encoding a glutamate / malate translocator, plasmids, bacteria, yeasts and plants containing these transporters
09/21/2000DE10013017A1 Verfahren zum Läutern eines viralen Antigens und zum Erzeugen eines Impfstoffes A method for refining a viral antigen and for producing a vaccine
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368152A1 Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367611A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000CA2367375A1 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000CA2367160A1 Leukotriene b4 receptor transgenic mammals
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2366054A1 Lentiviral vector system for high quantity screening
09/21/2000CA2365668A1 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365645A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types
09/21/2000CA2365540A1 A novel complex of human kallikrein 2 (hk2) and protease inhibitor-6 (pi-6) in prostate tumor tissue and methods of using the complex
09/21/2000CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
09/21/2000CA2365263A1 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2365102A1 Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
09/21/2000CA2364941A1 Novel protein and its use
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364667A1 Recombinant haemophilus influenzae adhesin proteins
09/21/2000CA2364650A1 50 human secreted proteins
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364630A1 50 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364580A1 Plants having modified reproductive capacity
09/21/2000CA2364568A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363686A1 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance
09/21/2000CA2363496A1 Differential expression of organellar gene products
09/21/2000CA2363024A1 Interleukin 17 receptor-like protein
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2363019A1 49 human secreted proteins
09/21/2000CA2362897A1 Plant centromeres
09/21/2000CA2361830A1 Method for acylating peptides and novel acylating agents
09/21/2000CA2361289A1 Compositions for promoting nerve regeneration
09/21/2000CA2361277A1 49 human secreted proteins
09/21/2000CA2328139A1 Photoinhibitory promoter
09/20/2000EP1036798A1 Peptides having anti-cell adhesion activity
09/20/2000EP1036200A2 Candida albicans kre9 and uses thereof
09/20/2000EP1036199A2 Cancer susceptibility mutations of brca1
09/20/2000EP1036198A1 Method for creating polynucleotide and polypeptide sequences
09/20/2000EP1036195A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036188A1 ribG
09/20/2000EP1036185A1 Proteinase inhibitor fusion proteins
09/20/2000EP1036182A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
09/20/2000EP1036181A1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelop of equine infectious anemia virus eiav
09/20/2000EP1036180A2 Circovirus sequences related to piglet weight loss disease (pwd)
09/20/2000EP1036179A1 Method for preparing polypeptides with appropriate glycosilation
09/20/2000EP1036178A1 Identification of lysolipid receptors involved in inflammatory response
09/20/2000EP1036177A1 Novel vectors and genes exhibiting increased expression
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036174A2 Novel peptide, apoep1.b, compositions and uses thereof
09/20/2000EP1036173A2 Methods and means for inducing apoptosis by interfering with bip-like proteins
09/20/2000EP1036172A1 SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS
09/20/2000EP1036171A2 Molecules interacting with apoptin
09/20/2000EP1036170A1 T-type voltage-gated calcium channels and method of using same
09/20/2000EP1036169A1 Nucleic acid mediated rna tagging and rna revision
09/20/2000EP1036168A1 Purification and microsequencing of hyaluronidase isozymes
09/20/2000EP1036167A2 Nuclear targeting by means of streptococcal protein h
09/20/2000EP1036164A1 Chemokine alpha-5
09/20/2000EP1036095A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
09/20/2000EP1036094A1 Cyp7 promoter-binding factors
09/20/2000EP1036093A1 Conjugates useful in the treatment of prostate cancer
09/20/2000EP1036092A2 Hydrophobically-modified protein compositions and methods
09/20/2000EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy
09/20/2000EP1036087A1 Secreted proteins and polynucleotides encoding them
09/20/2000EP1036086A1 Caspase-14 polypeptides
09/20/2000EP1035871A2 Oxidative method for attachment of glycoproteins or glycopeptides to surfaces of medical devices
09/20/2000EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
1 ... 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 ... 2916